Liberty One Investment Management, LLC Immunity Bio, Inc. Transaction History

Liberty One Investment Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	BUY	$1.25 - $5.21 $136 - $567	109 Added 0.23%	47,687 $239,000
Q3 2023 Nov 03, 2023	SELL	$1.29 - $3.1 $3,881 - $9,327	-3,009 Reduced 5.95%	47,578 $80,000
Q2 2023 Aug 04, 2023	BUY	$1.53 - $6.41 $30,137 - $126,264	19,698 Added 63.77%	50,587 $140,000
Q1 2023 May 15, 2023	BUY	$1.35 - $4.78 $1,093 - $3,871	810 Added 2.69%	30,889 $56,000
Q4 2022 Feb 15, 2023	SELL	$4.35 - $6.77 $187 - $291	-43 Reduced 0.14%	30,079 $152,000
Q3 2022 Nov 16, 2022	BUY	$3.65 - $6.43 $65,853 - $116,010	18,042 Added 149.35%	30,122 $150,000
Q2 2022 Aug 01, 2022	SELL	$2.68 - $6.14 $45,517 - $104,281	-16,984 Reduced 58.44%	12,080 $173,000
Q1 2022 May 03, 2022	SELL	$5.05 - $7.53 $103,020 - $153,612	-20,400 Reduced 41.24%	29,064 $163,000
Q4 2021 Jan 21, 2022	BUY	$5.67 - $10.18 $212,647 - $381,790	37,504 Added 313.58%	49,464 $301,000
Q3 2021 Oct 20, 2021	SELL	$9.17 - $14.24 $1,100 - $1,708	-120 Reduced 0.99%	11,960 $116,000
Q2 2021 Jul 20, 2021	BUY	$13.41 - $22.4 $161,992 - $270,592	12,080 New	12,080 $173,000

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Liberty One Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty One Investment Management, LLC with notifications on news.